| Regulation of gene expression by alternative untranslated regions TA Hughes Trends in Genetics 22 (3), 119-122, 2006 | 436 | 2006 |
| Nuclear and cytoplasmic expression of ERβ1, ERβ2, and ERβ5 identifies distinct prognostic outcome for breast cancer patients AM Shaaban, AR Green, S Karthik, Y Alizadeh, TA Hughes, L Harkins, ... Clinical Cancer Research 14 (16), 5228-5235, 2008 | 269 | 2008 |
| Surgery induced immunosuppression BV Hogan, MB Peter, HG Shenoy, K Horgan, TA Hughes The Surgeon 9 (1), 38-43, 2011 | 249 | 2011 |
| Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer R Verma, RE Foster, K Horgan, K Mounsey, H Nixon, N Smalle, ... Breast Cancer Research 18, 1-12, 2016 | 234 | 2016 |
| Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells BM Madhok, S Yeluri, SL Perry, TA Hughes, DG Jayne British journal of cancer 102 (12), 1746-1752, 2010 | 228 | 2010 |
| Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting JP Tiernan, SL Perry, ET Verghese, NP West, S Yeluri, DG Jayne, ... British journal of cancer 108 (3), 662-667, 2013 | 173 | 2013 |
| Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity LJ Coleman, MB Peter, TJ Teall, RA Brannan, AM Hanby, H Honarpisheh, ... British journal of cancer 100 (9), 1393-1399, 2009 | 163 | 2009 |
| HCF‐dependent nuclear import of VP16 S La Boissière, T Hughes, P O'Hare The EMBO journal, 1999 | 159 | 1999 |
| Estrogen receptor β1 expression is regulated by miR-92 in breast cancer H Al-Nakhle, PA Burns, M Cummings, AM Hanby, TA Hughes, ... Cancer research 70 (11), 4778-4784, 2010 | 133 | 2010 |
| MiR‐26b is down‐regulated in carcinoma‐associated fibroblasts from ER‐positive breast cancers leading to enhanced cell migration and invasion ET Verghese, R Drury, CA Green, DL Holliday, X Lu, C Nash, V Speirs, ... The Journal of pathology 231 (3), 388-399, 2013 | 129 | 2013 |
| In situ and invasive lobular neoplasia of the breast AM Hanby, TA Hughes Histopathology 52 (1), 58-66, 2008 | 129 | 2008 |
| Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours VJ Cookson, MA Bentley, BV Hogan, K Horgan, BE Hayward, ... Cellular Oncology 35, 301-308, 2012 | 102 | 2012 |
| Small is beautiful: microRNAs and breast cancer—where are we now? ET Verghese, AM Hanby, V Speirs, TA Hughes The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008 | 94 | 2008 |
| Exosomes and exosomal RNAs in breast cancer: A status update S Lakshmi, TA Hughes, S Priya European Journal of Cancer 144, 252-268, 2021 | 92 | 2021 |
| Mimosine arrests the cell cycle after cells enter S-phase TA Hughes, PR Cook Experimental cell research 222 (2), 275-280, 1996 | 83 | 1996 |
| Neoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancer B Kim, H Fatayer, AM Hanby, K Horgan, SL Perry, EMA Valleley, ... PLoS One 8 (5), e62766, 2013 | 74 | 2013 |
| Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy B Kim, SL Stephen, AM Hanby, K Horgan, SL Perry, J Richardson, ... BMC cancer 15, 1-12, 2015 | 68 | 2015 |
| Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signature J Hayes, H Thygesen, C Tumilson, A Droop, M Boissinot, TA Hughes, ... Molecular oncology 9 (3), 704-714, 2015 | 68 | 2015 |
| Targeting glucose metabolism: an emerging concept for anticancer therapy BM Madhok, S Yeluri, SL Perry, TA Hughes, DG Jayne American journal of clinical oncology 34 (6), 628-635, 2011 | 64 | 2011 |
| Cross-talk between pRb/E2F and Wnt/β-catenin pathways: E2F1 induces axin2 leading to repression of Wnt signalling and to increased cell death TA Hughes, HJM Brady Experimental cell research 303 (1), 32-46, 2005 | 49 | 2005 |
